Amedisys Reports Fourth Quarter and Year-End 2022 Financial Results, Issues 2023 Guidance, Announces Sale of Its Personal Care Line of Business and Signs Innovative Palliative Care at Home Partnership
Go back to Amedisys Reports Fourth Quarter and Year-End 2022 Financial Results, Issues 2023 Guidance, Announces Sale of Its Personal Care Line of Business and Signs Innovative Palliative Care at Home Partnership| Amedisys, Inc. (NASDAQ: AMED) | Delayed: 100.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $100.99 | 52 Week High | $55.16 | |||
| Open | $100.99 | 52 Week Low | $31.16 | |||
| Day High | $100.99 | P/E | N/A | |||
| Day Low | $100.99 | EPS | $-6.27 | |||
| Volume | 1,807 | |||||
